Drugs Made In America Acquisition Stock (NASDAQ:DMAA)
Previous Close
$10.08
52W Range
$9.95 - $10.27
50D Avg
$10.02
200D Avg
$10.02
Market Cap
$234.45M
Avg Vol (3M)
$224.00K
Beta
-
Div Yield
-
DMAA Company Profile
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Industry
Shell Companies
Sector
Financial Services
Exchange
NASDAQ
ADR
-
Country
US
Employees
-
IPO Date
-
Website
-